This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.20% per year. These returns cover a period from January 1, 1988 through April 1, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Zacks News
Best Growth Stocks to Buy for July 27th
by Zacks Equity Research
CWCO, AFYA and VRT made it to the Zacks Rank #1 (Strong Buy) growth stocks list on July 27, 2023.
Afya (AFYA) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
Afya (AFYA) closed at $15.59 in the latest trading session, marking a -0.89% move from the prior day.
5 Stocks With Recent Price Strength to Enhance Your Portfolio
by Nalak Das
Investors target stocks that are witnessing a bullish run. Some of the stocks seeing price strength are GBX, OII, OFG, AEHR, AFYA.
Best Growth Stocks to Buy for July 24th
by Zacks Equity Research
AFYA, AMWD and VRT made it to the Zacks Rank #1 (Strong Buy) growth stocks list on July 24, 2023.
AFYA vs. LOPE: Which Stock Is the Better Value Option?
by Zacks Equity Research
AFYA vs. LOPE: Which Stock Is the Better Value Option?
Afya (AFYA) Gains As Market Dips: What You Should Know
by Zacks Equity Research
Afya (AFYA) closed the most recent trading day at $15.73, moving +0.13% from the previous trading session.
Best Growth Stocks to Buy for July 20th
by Zacks Equity Research
AFYA, NSANY and TOL made it to the Zacks Rank #1 (Strong Buy) growth stocks list on July 20, 2023.
Best Growth Stocks to Buy for July 18th
by Zacks Equity Research
AFYA, NSANY and TOL made it to the Zacks Rank #1 (Strong Buy) growth stocks list on July 18, 2023.
Afya (AFYA) Stock Moves -0.07%: What You Should Know
by Zacks Equity Research
Afya (AFYA) closed the most recent trading day at $15.34, moving -0.07% from the previous trading session.
Best Growth Stocks to Buy for July 13
by Zacks Equity Research
AFYA, IDCC and SIEGY made it to the Zacks Rank #1 (Strong Buy) growth stocks list on July 13, 2023.
Afya (AFYA) Surges 7.5%: Is This an Indication of Further Gains?
by Zacks Equity Research
Afya (AFYA) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term.
AFYA or LOPE: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
AFYA vs. LOPE: Which Stock Is the Better Value Option?
5 Best PEG-Driven GARP Stocks for Investors
by Urmimala Biswas
Here are the five stocks that fit our screening criteria, TOL, PDCO, GEF, NXST and AFYA.
5 Stocks With Relative Price Strength Tailwinds at Their Back
by Nilanjan Choudhury
RCL, ALGT, AFYA, CASY and MTW are five stocks with explosive relative price strength.
Can Afya (AFYA) Run Higher on Rising Earnings Estimates?
by Zacks Equity Research
Afya (AFYA) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Wall Street Analysts See a 39.31% Upside in Afya (AFYA): Can the Stock Really Move This High?
by Zacks Equity Research
The mean of analysts' price targets for Afya (AFYA) points to a 39.3% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Best Growth Stocks to Buy for June 28th
by Zacks Equity Research
AFYA, ENS and PERI made it to the Zacks Rank #1 (Strong Buy) growth stocks list on June 28, 2023.
Best Value Stocks to Buy for June 28th
by Zacks Equity Research
CVLG, CNM and AFYA made it to the Zacks Rank #1 (Strong Buy) value stocks list on June 28, 2023.
Afya (AFYA) Lags Q1 Earnings Estimates
by Zacks Equity Research
Afya (AFYA) delivered earnings and revenue surprises of -12.82% and 0.82%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
Nerdy Inc. (NRDY) Reports Break-Even Earnings for Q1
by Zacks Equity Research
Nerdy Inc. (NRDY) delivered earnings and revenue surprises of 100% and 5.86%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
Adtalem Global Education (ATGE) Surpasses Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Adtalem (ATGE) delivered earnings and revenue surprises of 22.83% and 3.88%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
Afya (AFYA) Misses Q4 Earnings and Revenue Estimates
by Zacks Equity Research
Afya (AFYA) delivered earnings and revenue surprises of -16.13% and 4.39%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
American Public Education (APEI) Reports Q4 Loss, Lags Revenue Estimates
by Zacks Equity Research
American Public Education (APEI) delivered earnings and revenue surprises of -50% and 0.20%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Do Options Traders Know Something About Afya (AFYA) Stock We Don't?
by Zacks Equity Research
Investors need to pay close attention to Afya (AFYA) stock based on the movements in the options market lately.
Should Value Investors Buy Afya (AFYA) Stock?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.